Skip to main content
Site Logo

Download QR

Open Free Demat Account!

Join Our 9 Lakh Customers

+91
Headphone
HomeStocksKrishna Institute of Medical Sciences Ltd
Krishna Institute of Medical Sciences Ltd

Krishna Institute of Medical Sciences Ltd

Symbol:KIMS
Small Cap
LTP₹734.7
+11.7 (1.62%)
No chart data available for selected period

Fundamentals Ratios

Key Valuation Metrics

Market Cap₹30,343.37 Cr
P/E Ratio154.04
P/B Ratio7.2
Industry Ratio62.49
ROE5.40%
EPS (TTM)₹4.69
Dividend Yield- -
Book Value₹100.32
Face Value₹2
Sector P/E62.49
Outstanding Shares42.00 Cr
Beta0.74
Market Cap Type- -

Financial Statements

ParticularsMAR 2025MAR 2024MAR 2023MAR 2022
Sales Turnover3,035.12,498.142,197.681,650.83
Other Income42.713.0640.729.77
Total Revenue3,091.32,517.782,232.221,692.94
Total Expenditure2,255.61,857.021,580.771,141.54
Operating Profit835.7660.76651.45551.4
Interest100.454.5737.2821.87
Gross Profit735.3606.19614.17529.53
Depreciation177.2146.55129.2672.67
Profit Before Tax558.1459.64484.91456.86
Tax148119.61116.61112.89
Net Profit414.8336.01365.81343.8

About

Managing DirectorBhaskara Rao Bollineni
Auditor NameS R Batliboi & Associates LLP
Founded1973
Parent OrganizationKrishna Institute of Medical Sciences Ltd

Price Summary

Open

₹723

Prev Close

₹723

Today's High

₹739

Today's Low

₹720.8

52W High₹858
52W Low₹575.8
Volume39,668
Traded ValueN/A

Shareholding Pattern

Foreign Promoters and Groups
Indian Promoters and Groups
Non-Promoter Institutions
Non-Promoter Non-Institutions

Data as per latest exchange filings*

Frequently Asked Questions

Common questions about this stock, answered from live data

As of 08 Nov 2026, 3:30 pm, the share price of Krishna Institute of Medical Sciences Ltd (KIMS) is ₹734.7 on NSE and BSE.

Disclaimer: The FAQs above are generated based on historical and real-time market data provided by exchanges. This information is for educational purposes only and does not constitute financial advice, buy/sell recommendations, or price targets. Investment in the securities market is subject to market risks. Read all related documents carefully before investing.